Effect of diamfenetide on experimental infections of Fasciola hepatica in lambs: anthelmintic and clinical investigations.
The activity of diamfenetide (N,N'-[oxybis(2,1-ethan diyloxy-4,1-phenylene)] bis acetamide) was studied in lambs experimentally inoculated with Fasciola hepatica. The drug was given orally at a dose level of 100 mg/kg either 1,3,5,7, or 9 weeks postinoculation. It was 100% effective 1, 3, and 5 weeks postinoculation, 73% effective 7 weeks postinoculation, and 57% effective 9 weeks postinoculation. Serum gamma-glutamyl transpeptidase activity remained normal in all lambs for 5 weeks after infection; it then began to increase in infected, untreated lambs at 6 weeks, and had increased 5- to 6-fold 9 weeks postinoculation in infected lambs. This enzyme activity was the most sensitive hematologic parameter used in this test to detect hepatobiliary damage by the parasite. The drug was well tolerated at the dose level used.
D000083:Acetanilides / Q000031:analogs & derivatives*; D000818:Animals; D003957:Diamfenetide / Q000627:therapeutic use*; D005210:Fasciola hepatica; D005211:Fascioliasis / Q000188:drug therapy* / Q000201:enzymology; D012756:Sheep; D005723:gamma-Glutamyltransferase / Q000097:blood
D000083:Acetanilides; D005723:gamma-Glutamyltransferase; D003957:Diamfenetide